Finnzymes and Sage Science to Develop for Upstream and Downstream Analysis of PCR and qPCR Apps | GenomeWeb
This article updates an earlier version that incorrectly reported that the companies are co-developing PCR instruments.
 
NEW YORK (GenomeWeb News) — Finnzymes Instruments yesterday said it plans to use “core competencies” from Sage Science to develop a line of programmable instruments to be used in “key processes upstream and downstream analysis of PCR and qPCR applications.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.